(Q48832453)

16 February 2018

title

Development of antibody fragments for immunotherapy of prion diseases. (English)

1 reference

16 February 2018

0 references

1 reference

1 reference

8

1 reference

16 February 2018

Chiara Zurzolo

9

1 reference

16 February 2018

Mauro Giacca

object named as

Mauro Giacca

6

0 references

Stanley B. Prusiner

7

object named as

Stanley B Prusiner

1 reference

16 February 2018

Vincenza Campana

1

1 reference

16 February 2018

Lorena Zentilin

2

1 reference

16 February 2018

Ilaria Mirabile

3

1 reference

16 February 2018

Agata Kranjc

4

1 reference

16 February 2018

Philippe Casanova

5

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 March 2009

1 reference

16 February 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Biochemical Journal

1 reference

16 February 2018

volume

418

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

507-515

1 reference

16 February 2018

Heparan sulfate is a cellular receptor for purified infectious prions.

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Antiprion prophylaxis by gene transfer of a soluble prion antagonist

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Therapeutic approaches for prion disorders

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Mice devoid of PrP are resistant to scrapie

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Immunoaffinity purification and neutralization of scrapie prion infectivity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Approaches to therapy of prion diseases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Production of cattle lacking prion protein.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Monoclonal antibodies inhibit prion replication and delay the development of prion disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Comparative protein modelling by satisfaction of spatial restraints

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

A systematic review of prion therapeutics in experimental models

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Prion and doppel proteins bind to granule cells of the cerebellum

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

CNS delivery of vectored prion-specific single-chain antibodies delays disease onset

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Recent developments in prion immunotherapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Influence of pH on NMR structure and stability of the human prion protein globular domain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Anti-prion antibodies for prophylaxis following prion exposure in mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Delivery of interferon-beta to the monkey nervous system following intranasal administration

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Normal host prion protein necessary for scrapie-induced neurotoxicity.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

A new variant of Creutzfeldt-Jakob disease in the UK.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Modulation of proteinase-K resistant prion protein by prion peptide immunization.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

The Protein Data Bank

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

HADDOCK: a protein-protein docking approach based on biochemical or biophysical information

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1042/BJ20081541

Identifiers

DOI

10.1042/BJ20081541

1 reference

16 February 2018

PubMed ID

19000036

1 reference

16 February 2018